WPI 3620 (Armodafinil 50 mg)
Pill imprint WPI 3620 has been identified as Armodafinil 50 mg.
Armodafinil is used in the treatment of narcolepsy; shift work sleep disorder; obstructive sleep apnea/hypopnea syndrome; bipolar disorder; chronic fatigue syndrome (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 50 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Images for WPI 3620 (Armodafinil 50 mg)
Armodafinil is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...